Cowealth Medical China Co.,Ltd. (SHA:603122)
China · Delayed Price · Currency is CNY 12.37
+0.39 (3.26%)
At close: Sep 1, 2026
Cowealth Medical China Revenue
Cowealth Medical China had revenue of 184.40M CNY in the quarter ending June 30, 2026, a decrease of -3.92%. This brings the company's revenue in the last twelve months to 648.86M, down -21.44% year-over-year. In the year 2025, Cowealth Medical China had annual revenue of 677.79M, down -27.83%.
Revenue (ttm)
648.86M
Revenue Growth
-21.44%
P/S Ratio
7.59
Revenue / Employee
4.03M
Employees
161
Market Cap
4.92B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 677.79M | -261.35M | -27.83% |
| Dec 31, 2024 | 939.14M | -153.46M | -14.05% |
| Dec 31, 2023 | 1.09B | -187.06M | -14.62% |
| Dec 31, 2022 | 1.28B | 88.61M | 7.44% |
| Dec 31, 2021 | 1.19B | 102.04M | 9.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Shanghai Runda Medical Technology | 6.72B |
| Maccura Biotechnology Co.Ltd | 2.13B |
| Medicalsystem Biotechnology | 1.63B |
| Beijing Strong Biotechnologies,Inc. | 1.37B |
| Shanghai Labway Clinical Laboratory | 1.28B |
| Amoy Diagnostics | 1.18B |
| Berry Genomics Co.,Ltd | 929.15M |
| Thalys Medical Technology Group | 836.23M |